- Home
- XNCR vs UVV Comparison
XNCR vs UVV Comparison
Compare XNCR & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- UVV
- Stock Information
- Founded
- XNCR 1997
- UVV 1886
- Country
- XNCR United States
- UVV United States
- Employees
- XNCR N/A
- UVV N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- UVV Farming/Seeds/Milling
- Sector
- XNCR Health Care
- UVV Industrials
- Exchange
- XNCR Nasdaq
- UVV Nasdaq
- Market Cap
- XNCR 1.5B
- UVV 1.2B
- IPO Year
- XNCR 2013
- UVV N/A
- Fundamental
- Price
- XNCR $24.10
- UVV $55.68
- Analyst Decision
- XNCR Strong Buy
- UVV
- Analyst Count
- XNCR 8
- UVV 0
- Target Price
- XNCR $35.50
- UVV N/A
- AVG Volume (30 Days)
- XNCR 569.4K
- UVV 137.5K
- Earning Date
- XNCR 11-06-2024
- UVV 11-29-2024
- Dividend Yield
- XNCR N/A
- UVV 5.80%
- EPS Growth
- XNCR N/A
- UVV 5.05
- EPS
- XNCR N/A
- UVV 4.86
- Revenue
- XNCR $85,164,000.00
- UVV $2,827,901,000.00
- Revenue This Year
- XNCR N/A
- UVV N/A
- Revenue Next Year
- XNCR $86.53
- UVV N/A
- P/E Ratio
- XNCR N/A
- UVV $11.30
- Revenue Growth
- XNCR N/A
- UVV 6.40
- 52 Week Low
- XNCR $15.31
- UVV $45.19
- 52 Week High
- XNCR $26.84
- UVV $67.80
- Technical
- Relative Strength Index (RSI)
- XNCR 70.71
- UVV 66.77
- Support Level
- XNCR $22.60
- UVV $54.23
- Resistance Level
- XNCR $23.86
- UVV $55.55
- Average True Range (ATR)
- XNCR 0.83
- UVV 1.39
- MACD
- XNCR 0.05
- UVV 0.34
- Stochastic Oscillator
- XNCR 96.85
- UVV 92.14
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.